Ernexa Therapeutics
ERNA · NASDAQ
$2.24+$0.26 (+13.13%)TodayMarket closed ·
Prev close $1.98
Who owns ERNA
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 44.4% of ERNA’s shares.
- Cherington (Charles)23.2%
- Freebird Partners LP7.0%
- Regolith Capital Investments LP6.0%
- Halpern (John D)4.0%
- Next 6 largest institutions4.3%
- All other shareholders55.6%
| Holder | Shares | % of shares |
|---|---|---|
| Cherington (Charles) | 271.18K | 23.18% |
| Freebird Partners LP | 81.42K | 6.96% |
| Regolith Capital Investments LP | 69.91K | 5.97% |
| Halpern (John D) | 46.45K | 3.97% |
| Citadel Advisors LLC | 15.10K | 1.29% |
| IAF, LLC | 12.63K | 1.08% |
| Vanguard Fiduciary Trust Co | 8.34K | 0.71% |
| Dauntless Investment Group, LLC | 6.00K | 0.51% |
| Vanguard Capital Management, LLC | 5.68K | 0.49% |
| Purchase Capital LLC | 2.67K | 0.23% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Extended Market Index Fund | 5.68K | 0.49% |
| Fidelity Extended Market Index Fund | 5.57K | 0.48% |
| Fidelity Series Total Market Index Fund | 1.60K | 0.14% |
| Blackstone Alternative Multi-Strategy Fund | 2 | 0.00% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of ERNA in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Ratner Elena | Award | 5.94K | — |
| Cicala Peter | Award | 5.08K | — |
| Cicala Peter | Award | 5.94K | — |
| Luther Sanjeev | Award | 118.85K | — |
| Wexler William A. | Award | 5.94K | — |
| Polinsky David | Award | 5.08K | — |
| Bristol James Arthur | Award | 5.08K | — |
| Bristol James Arthur | Award | 8.32K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 19.73K
- Days to cover
- 1.00
- % of shares outstanding
- 1.69%
- Average daily volume
- 23.72K
- Change since last report
- +37.4%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.